Intravenous Iron Isomaltoside 1000 Reduces Postoperative Anemia in Patients Undergoing Elective Urologic Surgery and Those with Urosepsis.

Hyeok Jun Goh Ki Soo LeeTae Hyo KimKyu Nam KimHyun Jin LimKyu Shik KimWon Jae YangJung Ki Jo

Published in: Drug design, development and therapy (2020)

A single perioperative intravenous injection of IIM 1000 signiﬁcantly increased the Hb level in patients with anemia who underwent urologic elective surgery. Moreover, this treatment can be considered to have potential clinical beneﬁts for anemia caused by sepsis.

Keyphrases

patients undergoing
iron deficiency
minimally invasive
coronary artery bypass
chronic kidney disease
high dose
surgical site infection
acute kidney injury
intensive care unit
percutaneous coronary intervention
acute coronary syndrome
ultrasound guided
septic shock
climate change
human health